Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 1995;19(5):307-11.
doi: 10.1007/BF00130927.

The ophthalmological course of Usher syndrome type III

Affiliations
Multicenter Study

The ophthalmological course of Usher syndrome type III

L Pakarinen et al. Int Ophthalmol. 1995.

Abstract

Usher syndrome is a recessive hereditary disease group with clinical and genetical heterogeneity leading to handicapped hearing and visual loss until middle age. It is the most common cause for deaf-blindness. Three distinct phenotypes and five distinct genotypes are already known. In Finland the distribution of known Usher types is different than elsewhere. Usher syndrome type III (USH3) is common in Finland and it is thought to include 40% of patients. Progressive hearing loss is characteristic of USH3. Elsewhere USH3 has been regarded as a rarity covering only several percent of the whole Usher population. The aim of this paper is to describe, for the first time, the course of visual handicap and typical refractive errors in USH3 and compare it with other USH types. From a total patient sample consisting of 229 Finnish USH patients, 200 patients' visual findings were analyzed in a multicenter retrospective follow-up study. The average progress rate during a 10-year follow-up period in different USH types was similar. The essential progress occurred below the age of 40 and was continuous up to that age. Visual acuity dropped below 0.05 (severely impaired) at the age of 37 and the visual fields were of tubular shape without any peripheric islands at the average age of 30. Clinically significant hypermetropia with astigmatism seems to be a pathognomonic clinical sign of USH3.

PubMed Disclaimer

References

    1. Br J Ophthalmol. 1977 Jun;61(6):428-32 - PubMed
    1. J Otolaryngol. 1987 Mar;16(2):61-6 - PubMed
    1. Br Med J. 1960 May 7;1(5183):1394-8 - PubMed
    1. Arch Ophthalmol. 1986 Sep;104(9):1336-9 - PubMed
    1. Acta Ophthalmol (Copenh). 1984 Jun;62(3):391-400 - PubMed

Publication types

MeSH terms